Literature DB >> 11914688

Hypertensive diseases and eclampsia.

Jenny E Myers1, Philip N Baker.   

Abstract

Worldwide, pre-eclampsia and eclampsia contribute to the death of a pregnant woman every 3 min. In the UK in recent decades, hypertensive disorders of pregnancy have remained one of the leading causes of both maternal and perinatal morbidity and mortality. The management of pregnancies complicated by hypertension has not significantly altered for many years, possibly as a result of little progress being made in our understanding of the condition. New insights, however, have recently been gained into the pathophysiology of pre-eclampsia. These have yet to be translated into new interventions or to make any impact on clinical management of these pregnancies. This review will therefore focus on recent advances relating to research into the aetiology and pathogenesis of pre-eclampsia, but will conclude with a brief update on current therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11914688     DOI: 10.1097/00001703-200204000-00004

Source DB:  PubMed          Journal:  Curr Opin Obstet Gynecol        ISSN: 1040-872X            Impact factor:   1.927


  5 in total

1.  Thrombin activatable fibrinolysis inhibitor in preeclampsia and gestational hypertension throughout the gestation.

Authors:  Yinghong Zhang; Yu Hu; Tao Guo; Wenning Wei; Xiaoping Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-05-15

2.  The association between metabolic syndrome and vascular endothelial dysfunction in adolescents.

Authors:  Ying Wei; Geli Liu; Jingyan Yang; Rongxiu Zheng; Lihong Jiang; Pengli Bao
Journal:  Exp Ther Med       Date:  2013-04-09       Impact factor: 2.447

3.  Hypertensive disorders in pregnancy among pregnant women in a Nigerian Teaching Hospital.

Authors:  Swati Singh; Ekele Bissallah Ahmed; Shehu Constance Egondu; Nwobodo Emmanuel Ikechukwu
Journal:  Niger Med J       Date:  2014-09

4.  Preeclampsia is associated with alterations in the p53-pathway in villous trophoblast.

Authors:  Andrew N Sharp; Alexander E P Heazell; Dora Baczyk; Caroline E Dunk; Helen A Lacey; Carolyn J P Jones; Jonathan E Perkins; John C P Kingdom; Philip N Baker; Ian P Crocker
Journal:  PLoS One       Date:  2014-01-30       Impact factor: 3.240

Review 5.  Risk factors and effective management of preeclampsia.

Authors:  Fred A English; Louise C Kenny; Fergus P McCarthy
Journal:  Integr Blood Press Control       Date:  2015-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.